Elbit Imaging Ltd. (EMITF)

0,8000 -0,0500 (-5,88%) Ab 10:33AM EDT. Markt geöffnet.

Elbit Imaging Ltd.

3 Shimson Street
Petah Tikva 4900102
Israel
972 3 608 6000

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Ron Hadassi BA, LL.B, MBA	CEO & Chairman of the Board of Directors	1,21M	N/A	1965
Ms. Ricky Steiner	Chief Financial Officer	697k	N/A	1976
Ms. Tzipi Siani-Amosi	Chief Financial Officer of Elbit Medical	602k	N/A	1973
Dr. Maurice R. Ferre M.D.	Chairman of the Board & CEO of Insightec Ltd	1,82M	N/A	1961
Mr. Jun Tao	Chief Commercial Officer of InSightec Ltd	1,58M	N/A	1966

Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petah Tikva, Israel.

Corporate Governance

Elbit Imaging Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.